21 Recruiting Studies Using Risankizumab
Active clinical trials that use this intervention, sourced directly from the NIH registry.
Browse by conditionTrials Using Risankizumab
A Study to Assess Adverse Events and Change in Disease Activity of Risankizumab Subcutaneous Induction Treatment for Moderately to Severely Active Crohn's Disease.
📍 Gi Alliance - Arizona Digestive Health - Sun City /ID# 268178 — Sun City, Arizona
Crohn's Disease
View Study & Checklist ➔A Study of the Efficacy and Safety of Risankizumab in Participants With Crohn's Disease
📍 Digestive Disease Consultants, A Division of Arizona Digestive Health, P.C /ID# 211884 — Mesa, Arizona
Crohn's Disease
View Study & Checklist ➔Study to Evaluate Adverse Events and Change in Disease Activity in Participants Between 6 and 17 Years With Moderate to Severe Plaque Psoriasis Treated With Subcutaneous (SC) Injection of Risankizumab Who Have Completed Participation in Study M19-977
📍 UAB Department of Dermatology /ID# 252305 — Birmingham, Alabama
Psoriasis
View Study & Checklist ➔A Study to Assess the Change in Disease Activity in Adult Participants With Moderate to Severe Ulcerative Colitis Treated With Risankizumab Compared to Vedolizumab
📍 Gastro Health Research - St. Vincent'S East /ID# 275089 — Birmingham, Alabama
Ulcerative Colitis
View Study & Checklist ➔Study Comparing Intravenous (IV)/Subcutaneous (SC) Risankizumab to IV/SC Ustekinumab to Assess Change in Crohn's Disease Activity Index (CDAI) in Adult Participants With Moderate to Severe Crohn's Disease (CD)
📍 Advanced Gastroenterology, P.C /ID# 224396 — Chandler, Arizona
Crohn's Disease (CD)
View Study & Checklist ➔VOICE-Early Response to Vedolizumab and IL-23 Antagonists in Participants With Crohn's Disease: A Prospective Observational Study
📍 GI Alliance - Sun City — Sun City, Arizona
Crohn's Disease
View Study & Checklist ➔A Study to Assess the Efficacy and Safety of Risankizumab in Participants With Ulcerative Colitis
📍 Southern California Res. Ctr. /ID# 169659 — Coronado, California
Ulcerative Colitis (UC)
View Study & Checklist ➔A Study Comparing Risankizumab to Placebo in Participants With Active Psoriatic Arthritis (PsA) Who Have a History of Inadequate Response to or Intolerance to at Least One Disease Modifying Anti-Rheumatic Drug (DMARD) Therapy
📍 Pinnacle Research Group /ID# 167955 — Anniston, Alabama
Psoriatic Arthritis
View Study & Checklist ➔Costa Rican Registry of IL-23 Inhibitors in Psoriatic Disease
📍 Caja Costarricense del Seguro Social — San José, Provincia de San José
Psoriasis
View Study & Checklist ➔Utilization of a Microdevice for Psoriasis and Atopic Dermatitis
📍 University of California, San Francisco — San Francisco, California
Psoriasis
View Study & Checklist ➔Study of Targeted Therapies for the Treatment of Adult Participants With Moderate to Severe Crohn's Disease
📍 Digestive Health Specialists /ID# 266216 — Dothan, Alabama
Crohn's Disease
View Study & Checklist ➔A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
📍 Digestive Health Specialists of the Southeast — Dothan, Alabama
Crohn Disease
View Study & Checklist ➔Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
📍 Digestive Health Specialists /ID# 280827 — Dothan, Alabama
Crohn's Disease
View Study & Checklist ➔A Study to Assess Adverse Events, Change in Disease Activity, and How Intravenous and Subcutaneous Risankizumab Moves Through the Body of Pediatric Participants With Moderately to Severely Active Crohn's Disease
📍 Phoenix Children's Hospital /ID# 255766 — Phoenix, Arizona
Crohn's Disease
View Study & Checklist ➔A Study to Learn More About How Risankizumab Works in Young Participants With Ulcerative Colitis
📍 Phoenix Children's Hospital /ID# 273015 — Phoenix, Arizona
Ulcerative Colitis
View Study & Checklist ➔A Study to Assess How Intravenous and Subcutaneous Administrations of Risankizumab Moves Through the Body of Healthy Adult Participants
📍 CenExel ACT- Anaheim Clinical Trials /ID# 281821 — Anaheim, California
Healthy Volunteer
View Study & Checklist ➔Study of Targeted Therapies for the Treatment of Adult Participants With Active Psoriatic Arthritis
📍 Newport Huntington Medical Group /ID# 272764 — Huntington Beach, California
Psoriatic Arthritis
View Study & Checklist ➔Study to Evaluate Pregnancy Outcomes in Risankizumab Exposed Pregnancies Relative to Those Non-risankizumab Exposed Pregnancies in Women With FDA Approved Indications
📍 Evidera, a PPD Business Unit /ID# 238688 — Morrisville, North Carolina
Plaque Psoriasis, Psoriatic Arthritis, Crohn's Disease, or Other Conditions for Which Risankizumab is an FDA-approved Treatment
View Study & Checklist ➔Evaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate Response
📍 Clinical Site — Avondale, Arizona
Arthritis, Psoriatic
View Study & Checklist ➔A Study to Assess Adverse Events, Change in Disease Activity, and How the Drug Moves Through the Body in Children With Juvenile Psoriatic Arthritis (jPsA) Receiving Subcutaneously Injected Risankizumab or Adalimumab
📍 Arkansas Children's Hospital /ID# 258776 — Little Rock, Arkansas
Juvenile Psoriatic Arthritis
View Study & Checklist ➔Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty
📍 NYU Langone Health — New York, New York
Rheumatic Disease
View Study & Checklist ➔